CollPlant Biotechnologies (CLGN) Receivables (2017 - 2025)
CollPlant Biotechnologies (CLGN) reported Receivables of $1,000 for the quarter ended Dec 31, 2025, down 99.3% from $150,000 a year earlier and down 90.9% from the prior quarter.
Powered by 
Analysis
CollPlant Biotechnologies (CLGN) Receivables (2017 - 2025) Analysis & Trends
Dating back to the quarter ended Dec 31, 2017, CollPlant Biotechnologies' Receivables record includes 29 quarters.
- Receivables has a five-year compound annual growth rate of -73.9% (years ended Dec 2020 to Dec 2025).
- By year, Receivables came in at $150,000 in the year ended Dec 31, 2024, $9,000 in the year ended Dec 31, 2022 (-96.7%) and $270,000 in the year ended Dec 31, 2021 (-67.5%).
- The figure for the quarter ended Dec 31, 2025 ranks as the lowest quarterly Receivables in data going back to the quarter ended Dec 31, 2017.
- Year over year, Receivables gained in two of the last five quarters, with an average decline of 24.8%.
- The high point for year-over-year Receivables in five years was the quarter ended Sep 30, 2025 (growth of 120.0%); the low point was the quarter ended Dec 31, 2025 (a decline of 99.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | CollPlant Biotechnologies | 4.95 Mn | 4.95 Mn | -243,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Dec 31, 2024 | 150,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 250,000.00 |
| Mar 31, 2024 | 90,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 10.16 Mn |
| Mar 31, 2023 | 323,000.00 |
| Dec 31, 2022 | 9,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Dec 31, 2021 | 270,000.00 |
| Sep 30, 2021 | 135,000.00 |
| Jun 30, 2021 | 277,000.00 |
| Mar 31, 2021 | 174,000.00 |
| Dec 31, 2020 | 830,000.00 |
| Sep 30, 2020 | 891,000.00 |
| Jun 30, 2020 | 321,000.00 |
| Mar 31, 2020 | 398,000.00 |
API Access
CollPlant Biotechnologies Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=CLGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "CLGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=CLGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();